Case fatality of COVID-19 in patients with neurodegenerative dementia | Zendy

José Antonio Reyes-Bueno | Zendy; Natalia MenaVázquez | Zendy; T. Ojea-Ortega | Zendy; M.M. Gonzalez-Sotomayor | Zendy; Pablo CabezudoGarcía | Zendy; Nicolás Lundahl Ciano-Petersen | Zendy; Gracia Pons-Pons | Zendy; María Victoria Castro-Sánchez | Zendy; Pedro Jesús Serrano Castro | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Case fatality of COVID-19 in patients with neurodegenerative dementia

Author(s) -

José Antonio Reyes-Bueno,

Natalia MenaVázquez,

T. Ojea-Ortega,

M.M. Gonzalez-Sotomayor,

Pablo CabezudoGarcía,

Nicolás Lundahl Ciano-Petersen,

Gracia Pons-Pons,

María Victoria Castro-Sánchez,

Pedro Jesús Serrano Castro

Publication year - 2020

Publication title -

neurología (english edition)

Language(s) - English

Resource type - Journals

ISSN - 2173-5808

DOI - 10.1016/j.nrleng.2020.07.006

Subject(s) - medicine , covid-19 , dementia , case fatality rate , cohort , population , pediatrics , epidemiology , disease , environmental health , infectious disease (medical specialty)

The elderly population is the group most threatened by COVID-19, with the highest mortality rates. This study aims to analyse the case fatality of COVID-19 in a cohort of patients with degenerative dementia.METHODSWe conducted a descriptive case-control study of a sample of patients diagnosed with primary neurodegenerative dementia.RESULTSTwenty-four of the 88 patients with COVID-19 included in the study died: 10/23 (43.4%) patients diagnosed with dementia and 14/65 (21.5%) controls; this difference was statistically significant.DISCUSSIONOur results suggest that case fatality of COVID-19 is significantly higher among patients with primary degenerative dementia than in other patients with similar mean ages and comorbidities.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research